The quickest way to find your next biotech investment
BPIQ provides you with data on over over 550 micro to mid cap biotech stocks. This includes info for over 1,800 drug assets, upcoming clinical trial readouts, other FDA catalyst events, and more!
Try risk-free, no credit card required
Searchable FDA Catalyst Calendar
The biotech space is complicated, we understand. That’s why we’ve compiled data on over 550 micro to mid cap biotech stocks, over 1,800 of their drug assets, of which over 1,000 have upcoming FDA catalyst events. Access the data and tools you need to jumpstart your diligence. Take a look inside.
How to use the BPIQ Platform
Discover opportunities by filtering our FDA Catalyst Calendar to fit your criteria
Identify potential big moving events with our volatility based Big Mover Events
Conduct deep diligence with our searchable Drug Pipeline Screener
Jumpstart your analysis with our detailed Drug IQ Pages
Are you wasting time finding plays? Source potential big movers and bolster up your watchlist
Spot catalyst events with set dates so you are fully prepared at market open
Discover potential big movers with our volatility based Big Mover Events
Gain an advantage by understanding the fundamental side with our educational videos
Who is Biopharm IQ for?
Make better investment decisions than your peers by combining your expertise with our tools
Easily find catalyst events that fit your criteria
Quickly analyze assets that catch your eye with our detailed drug pages
Uncover potential big movers with our volatility based Big Mover Events
See what BPIQ users are saying
“Really loving the site over the competitor... like the layout and speed over the competition... like the individual pages for each drug/treatment”
- Mike from United States
Why Choose BPIQ?
BPIQ offers more tools, at a more affordable price. We are biotech investors ourselves so we understand your needs and pain points. We are focused on giving you the tools you need to succeed, not just what's easy for us to make.
We are also quickly adding new features. See how we stack up against the competition in this chart.